Environmental exposure of primary care personnel to ribavirin aerosol when supervising treatment of infants with respiratory syncytial virus infections.
Antimicrob Agents Chemother
; 31(7): 1143-6, 1987 Jul.
Article
en En
| MEDLINE
| ID: mdl-3662474
The potential exposure to ribavirin aerosol in the environment was assessed in nurses caring for infants and children with severe lower respiratory tract infections due to respiratory syncytial virus. Ribavirin aerosol was administered via a ventilator, oxygen tent, or oxygen hood. Participants worked directly with infants receiving ribavirin for 20.0 to 35.0 h over a 3-day period. No toxic or adverse effects of ribavirin aerosol were observed in any of the 19 nurses studied, and ribavirin was not detected in erythrocytes, plasma, or urine collected after the potential exposure period.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Infecciones por Respirovirus
/
Ribavirina
/
Ribonucleósidos
/
Enfermeras y Enfermeros
Límite:
Adult
/
Female
/
Humans
/
Infant
Idioma:
En
Revista:
Antimicrob Agents Chemother
Año:
1987
Tipo del documento:
Article
Pais de publicación:
Estados Unidos